In the present study, we found that, in addition to CCL2, NMO-IgG was able to activate the release of multiple cytokines, such as IL-6, CXCL1, IL-1β, IL-17A, and IL-18 (Figure 3E). The gene discussed is IL6; the disease is neuromyelitis optica.